行业支付对辅助生殖技术实践及结局影响的回顾性比较
该回顾性队列研究利用2020年Open Payments数据库和美国CDC数据,分析873名生殖内分泌与不孕症医生获得的行业支付与辅助生殖技术实践及结局的关联。总体上活产率、ICSI率、FET率、PGT率及>40岁患者比例在医生受支付比例不同的中心间无显著差异;但在99个大型中心(≥5名医生)中,医生受支付比例每增加,PGT率增加0.20%(95%CI 0.02-0.39),FET率增加0.14%(95%CI 0.05-0.24),活产率、ICSI率及>40岁患者比例无关联。作者认为需进一步研究以确定这些差异反映的是行业支付影响还是大型实践中个体中心/提供者的实践习惯。
要点
- 总体而言,行业支付与IVF中心结局差异无关。
- 大型中心医生受支付比例越高,PGT和FET使用率略增。
- 活产率、ICSI率及>40岁患者比例与行业支付比例无关。
核心结论
- 行业支付总体上与体外受精中心结局差异无关。
- 医生受行业支付比例较高的大型中心可能更倾向于使用PGT和FET等额外操作,但最终结局如活产率未改善。
- 需进一步研究以确定这些差异反映的是行业支付影响还是大型实践中个体中心/提供者的实践习惯。
研究设计与样本
- 回顾性队列研究,分析2020年Open Payments数据库中报告的行业支付。
- 患者为接受辅助生殖的患者,结局数据来自美国CDC 2020年数据库。
- 采用线性回归分析比较每个中心接受行业支付的医生百分比与临床层面结局。
主要发现
- 2020年数据库中共有873名生殖内分泌与不孕症医生获得支付;在1,724名生殖内分泌与不孕症医生中,873名(50.6%)在2020年至少获得一次支付。
- 80.5%(437/543)的体外受精中心至少有一名医生获得支付。
- 按医生接受行业支付百分比分组,活产率、ICSI率、FET率、PGT率及>40岁患者百分比在中心间无显著差异。
- 在99个大型中心(定义为≥5名医生)的子分析中,医生接受行业支付百分比每增加,PGT率增加0.20%(95%CI 0.02-0.39),FET率增加0.14%(95%CI 0.05-0.24)。
- 活产率、ICSI率及>40岁患者百分比与医生行业支付率增加无关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需进一步研究以确定这些差异反映的是行业支付影响还是大型实践中个体中心/提供者的实践习惯。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether industry payments to physicians are associated with a difference in assisted reproductive technology practices and outcomes. DESIGN: Retrospective cohort. PATIENT(S): Patients undergoing asissted reproduction. INTERVENTION(S): Industry payments reported to the Open Payments 2020 database. MAIN OUTCOME MEASURE(S): The live birth rate, frozen embryo transfer (FET) rate, intracytoplasmic sperm injection (ICSI) rate, preimplantation genetic testing (PGT) rate, and percentage of patients aged >40 years were obtained from the Centers for Disease Control and Prevention 2020 database. Linear regression analysis was performed comparing the percentage of physicians per center receiving industry payments to clinic-level outcomes. RESULT(S): A total of 873 reproductive endocrinology and infertility physicians received payments in the 2020 database. At least one physician received a payment in 80.5% (437/543) of in vitro fertilization centers. Of 1,724 reproductive endocrinology and infertility physicians, 873 (50.6%) received at least one payment in 2020. The live birth, ICSI, FET, and PGT rates and percentage of patients aged >40 years did not significantly differ between centers by percentage of physicians receiving industry payments. However, in the subanalysis of 99 large centers (defined as ≥5 physicians), each increase in the percentage of physicians receiving industry payments was associated with increases of 0.20% (95% confidence interval, 0.02-0.39) and 0.14% (95% confidence interval, 0.05-0.24) in the PGT and FET rates, respectively. The live birth, ICSI rates and percentage of patients aged >40 years were not associated with increased industry payment rates to physicians. CONCLUSION(S): Industry payments were not associated with differences in in vitro fertilization center outcomes overall. However, large centers with more physicians receiving industry payments may be more likely to use additional procedures such as PGT and FET, without improvement in the final outcomes such as the live birth rate. Further research is needed to determine whether these differences reflect the industry payment influence vs. individual center/provider practice habits in larger practices.
引用
- Jain M, Blanco-Briendel M, Wu H, et al. A retrospective comparison of the impact of industry payments on assisted reproductive technology practice and outcomes. Fertil Steril. 2024. PMID: 39098540. doi:10.1016/j.fertnstert.2024.07.998
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。